Desktop Site
|
19 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,088.33
+599.34
+0.83 %
Corporate Announcement
Security Code
530019
Company
Jubilant Pharmova Ltd
Exchange Received Time
27/05/2020 17:44:13
Exchange Disseminated Time
27/05/2020 17:44:19
Time Taken
00:00:06
Format of Initial Disclosure to be made by an entity identified as a Large Corporate |
5/27/2020 5:44:14 PM
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No.
Particulars
Details
1
Name of Compay
JUBILANT LIFE SCIENCES LIMITED
2
CIN
L24116UP1978PLC004624
3
Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)
742.21
4
Highest Credit Rating during the previous FY
AA
4a
Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)
INDIA RATINGS AND RESEARCH PVT. LTD.
5
Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework
NSE
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES
Name of the Company Secretary: Rajiv Shah
Designation: Company Secretary
EmailId: rajiv.shah@jubl.com
Name of the Chief Financial Officer: Alok Vaish
Designation: Chief Financial Officer
EmailId: alok.vaish@jubl.com
Date: 27/05/2020
Note:
In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Attachment
<< Back
Recently Viewed